TrialFrontiers in immunology2026

Real-world study of SHR-1210 plus apatinib in the treatment of BRAF-negative mucosal melanoma: efficacy, safety and implications of precision medicine.

Yong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.